116 filings
Page 2 of 6
8-K
6m7vf2
29 Mar 23
CRISPR Therapeutics Announces Departure of Board Member
8:08am
8-K
xsrg8gtjxi0nb2
27 Mar 23
Entry into a Material Definitive Agreement
8:08am
8-K
t8tdw
14 Mar 23
CRISPR Therapeutics Announces Transition of Chief Financial Officer
8:15am
8-K
c4h2 hjv48a
21 Feb 23
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results
4:06pm
8-K
075sih qd0i5uc09mmw
1 Nov 22
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results
4:05pm
8-K
u4p9v0a
27 Oct 22
CRISPR Therapeutics Announces Planned Transition of Chief Operating Officer
8:36am
8-K
espa7n
27 Sep 22
Vertex and CRISPR Therapeutics Announce Global exa-cel Regulatory Submissions for Sickle Cell Disease and Beta Thalassemia in 2022
7:48am
8-K
bnyluoussh
8 Aug 22
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results
8:05am
8-K
3a4zuzuwv1ek6c1l2sq
21 Jun 22
Other Events
5:05pm
8-K
gg2jt7m
13 Jun 22
Departure of Directors or Certain Officers
4:58pm
8-K
abk 3tmvi8flaem
13 Jun 22
Regulation FD Disclosure
8:02am
8-K
ua64z6oc
16 May 22
CRISPR Therapeutics Announces the Appointment of Phuong Khanh Morrow, M.D., FACP, as Chief Medical Officer
4:14pm
8-K
8j448sbxc2xs0e3ksa
12 May 22
Regulation FD Disclosure
4:05pm
8-K
6527 ew786nbwyvtw9k
9 May 22
Results of Operations and Financial Condition
4:06pm
8-K
y0ambkp9hc7vun3t67v3
15 Feb 22
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
4:05pm
8-K
iocimj23jth58xakcfq
20 Dec 21
Departure of Directors or Certain Officers
8:00am
8-K
0ulyhv mj53o
22 Nov 21
Regulation FD Disclosure
8:42am
8-K
fyyfr2iof4hs54mm
3 Nov 21
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results
4:07pm
8-K
w264bqa2ca
14 Oct 21
CRISPR Therapeutics Announces Transition of Chief Financial Officer
7:15am
8-K
ktw3erp7z t8
12 Oct 21
CRISPR Therapeutics Reports Positive Results from its Phase 1 CARBON Trial of CTX110™ in Relapsed
4:46pm